Transdermal nitroglycerin patches in congestive heart failure: evaluation by continuous hemodynamic monitoring for 72 hours.
D000279:Administration, Cutaneous; D000368:Aged; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D005996:Nitroglycerin / Q000008:administration & dosage*
D005996:Nitroglycerin